All the organisms isolated from this study
shows100% sensitivity to Ceftriaxone except E coli
(33.3%). Also, Erythromycin shows 100% resistance to
all the organisms except Staph aureus that was 60%
sensitive. This is important because Erythromycin and
Ceftriaxone are the common antibiotic used in our
practice.
In the present study 56.4% of the patients
delivered preterm with highest percentage of 39.6%
occurring at gestational age between 28 – 33 weeks, this
is comparable to findings of Isaac et al (30-32 weeks).26
And most of the patients presented < 12-hour onset of
PROM and had latency period of >24-hours.
Spontaneous vaginal delivery was the mode of delivery
in 51.5% of the patients. This was similar to findings
from various studies, 25,26,27 because PROM alone is not
a contraindication to vaginal delivery. Those that had
caesarean section have other added obstetric
indications.
Total of 101 neonates were delivered during the
study period, 51.5% of them were admitted into
neonatal intensive care unit due to various indication
notably prematurity, low birth weight and birth
asphyxia. Only 3%of the neonate developed neonatal
sepsis this is similar to 2.9% finding of Shivaraju et al27
but lower than that of Isaac et al (10%).26 The study also
has no cases of endometritis during the puerperium
which is similar to the findings of Salou et al[14] this
could be due to the prophylactic antibiotic given to the
patients.
CONCLUSSION
Microbial organisms were isolated in 20.9% of the
patients, the common organisms are Candida albicans,
staphylococcus aureus and Escherichia coli.
Ceftriaxone, Imepenem and Amoxyclav are the most
sensitive antibiotics. Therefore, Prophylactic use of
antibiotic should be based on demonstrated microbial
pattern and their sensitivity, also periodic review of
these findings is necessary to look for emergence of
antibiotic resistance and abuse. There is also need to
further explore the association of candida with PROM
as the commonest organism isolated in the study.
Limitations
Some microorganism like Chlamydia tracomatis and
Mycoplasma spp could not be isolated due to lack of
facility for their identification.
Recommendation
In light of the above, the study would recommend the
following;
1. Ceftriaxone is recommended to be used in
combination with Erythromycin as prophylaxis for
PROM.
2. Routine endocervical swab should be taken in
patient with PROM.
3. Further research is needed to explore the association
of candida with PROM and other risk factors.
REFERENCE
1. 1.Jesus RA, Joseph JA. Controversies in the management
of preterm premature rupture of membranes. In: Studd J,
Tan L, Chervenk A, (ed) Progress in Obstetrics and
Gynecology. Elsevier, Churchill Livingstone, volume 18,
2008; p203 – 217.
2. Thomas FB, Andrew AC, Sabaratnam A. Premature
prelabour rupture of membranes. In: Munro Kerr’s
Operative Obstetrics. Elsevier, Eleventh edition, 2007,
p88-89.
3. D C Dutta’s Text Book of Obstetrics including
perinatology and contraception, Konor H(ed), New Delhi,
7th edition,2013; p317 – 318.
4. Philip B. Preterm prelabour rupture of membranes. In:
Edmond D(ed) Dewhurst’s Text Book of Obstetrics and
Gynaecology. Wiley-blackwel, London, Eight edition,
2012, p353-354.
5. Eleje GU, Adinma JI, Ugwuanyi DC, Ikechebelu JI,
Okafor CI, Ezeanma CO, et al. Genital tract microbial
isolate in women with preterm pre labour rupture of
membranes in resource-constrained community setting. J
Obstet Gynaecol, 2014; p1-4
6. Mercer B. Preterm premature rupture of the membranes.
Glob. libr. Women’s Med., (ISSN:1756-2228)2008; Dol
10.3843/GLOWM. 10120. Available from
https://www.glowm.com
7. Allahyar J. Premature rupture of membrane.
(online)2016;1-8. Available from
http://emedicine.medscape.com/
article/261137. (accessed on 6/9/2016).
8. Royal College of Obstetricians and Gynaecologist.
Preterm prelabour rupture of membranes. Green Top
Guideline No 44. London; 2006.
9. Aboyeji A, Abdul I, Jaiya M, NwabusiC, Ologe M. The
bacteriology of prelabour rupture of membranes in a
Nigerian Teaching hospital. J. Obset Gynaecol. 2005;
25(8): p761-764.
10. Ducherny AH, Lauren N, Roman AS. Premature rupture
of membranes. In Names of editors: Current Diagnosis
and Treatment Obstetrics and Gynecology. McGraw Hill
companies, New York, 11th ed, 2013, p 257-260.
11. Kenyon SL. Broad-spectrum antibiotic for preterm
premature rupture of fetal membranes; The Oracle 1
Randomized Trial. Lancet 2001; 357: 979-988.
12. Odunsi A, Odutayo R. Premature rupture of fetal
membranes. In: Okonofua F, Odunsi K(ed) Contemporary
Obstetrics and Gynaecology for Developing Countries.
WHARC, Nigeria, 2003, p430-448.
13. Aday LA, Cornelius LJ. Deciding how many will be in the
sample. In: Designing and conducting health surveys: A
comprehensive guide, 3rd ed. San Franscisco: Jossey-
Bass; 2006. P154-193.
14. Salou M, Lack F, Adama-hondegle AB, Dossin S,
Tsagbale N, Gbadoe A, et al. Premature Rupture of the
Membrane at Sylvanus Olympio University Hospital of
Lome Togo: Microbiological findings and Outcomes. Am
J Infect Dis Microbiol 2015; 3(6): 152 – 156.
15. Forbes BA. Principles of bacteria identification. In:
Forbes BA, Sahm DF, Weissfeld AS (ed) Baily and Scoots